PFE - Pfizer Inc.

NYSE - NYSE Delayed Price. Currency in USD

Pfizer Inc.

235 East 42nd Street
New York, NY 10017
United States
212-733-2323
http://www.pfizer.com

SectorHealthcare
IndustryDrug Manufacturers—General
Full Time Employees88,300

Key Executives

NameTitlePayExercisedYear Born
Dr. Albert Bourla D.V.M., DVM, Ph.D.Chairman & CEO5.84M2.12M1962
Mr. John D. YoungGroup Pres & Chief Bus. Officer3.36M3.83M1965
Mr. Frank A. D'AmelioCFO & EVP of Global Supply & Bus. Operations3.84M8.47M1958
Dr. Mikael DolstenChief Scientific Officer and Pres of Worldwide Research, Devel. & Medical3.66M7.93M1959
Ms. Jennifer B. DamicoSr. VP, Controller & Principal Accounting OfficerN/AN/A1968
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including internal medicine, such as cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; oncology, such as biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Sutent, Xtandi, Xalkori, Inlyta, Braftovi + Mektovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Vfend, and Zithromax brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, and tick-borne encephalitis under the Prevnar 13/Prevenar 13 (pediatric/adult), FSME-IMMUN, Nimenrix, and Trumenba brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, Genotropin, and Refacto AF/Xyntha brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration and/or co-promotion agreements with Bristol-Myers Squibb Company and Astellas Pharma US, Inc.; licensing agreement with Akcea Therapeutics, Inc; strategic alliance with Verily Life Sciences LLC; a collaboration agreement with Merck KGaA; clinical trial collaboration and supply agreement with IDEAYA Biosciences, Inc.; a material transfer and collaboration agreement with BioNTech SE to co-develop COVID-19 vaccine; and a clinical supply collaboration Jiangsu Alphamab Biopharmaceuticals Co., Ltd. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Corporate Governance

Pfizer Inc.’s ISS Governance QualityScore as of December 3, 2019 is 1. The pillar scores are Audit: 1; Board: 6; Shareholder Rights: 1; Compensation: 1.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.